" class="no-js "lang="en-US"> Houman Ashrafian Archives - Pharmtech Focus
Thursday, January 26, 2023

Breaking News

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs Sharecare Launches VR Program to Improve Well-being of American Workforce Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment Cerebral Therapeutics Names Julie Foster as Chief Operating Officer Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products Daewoong Pharmaceutical Submitted NDA for its Global New Drug Fexuclue in 11 Countries Roche launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-variant ProPharma Acquires UK Based Digital Lab Consulting

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting | PTF

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Read more

Fundraising

 Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform | Pharmtech Focus

Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform

Quell Therapeutics Ltd (“Quell”), the world leader in the development of engineered T-regulatory (Treg) cell […]

  1. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome

    Diseases

     Read more
  2. Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs

    News

     Read more
  3. Sharecare Launches VR Program to Improve Well-being of American Workforce

    News

     Read more
  4. Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer

    News

     Read more
  5. Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment

    News

     Read more